Abstract:AIM: To investigate the expression of myofibrillogenesis regulator-1 (MR-1) in relation to clinicopathological parameters and postoperative survival in a group of Chinese patients with gastric cancer.METHODS: In our previous study of human whole-genome gene expression profiling, the differentially expressed genes were detected in the gastric cancer and its adjacent noncancerous mucosa. We found that MR-1 was associated with the location and differentiation of tumors. In this study, MR-1 protein expression was determined by immunohistochemistry in specimens of primary cancer and the adjacent noncancerous tissues from gastric cancer patients. A set of real-time quantitative polymerase chain reaction assays based on the Universal ProbeLibrary-a collection of 165 presynthesized, fluorescence-labeled locked nucleic acid hydrolysis probes-was designed specifically to detect the expression of MR-1 mRNA. The correlation was analyzed between the expression of MR-1 and other tumor characteristics which may influence the prognosis of gastric cancer patients. A retrospective cohort study on the prognosis was carried out and clinical data were collected from medical records.RESULTS: MR-1 mRNA and protein could be detected in gastric cancer tissues as well as in matched noncancerous tissues. MR-1 was up-regulated at both mRNA (5.459 +/- 0.639 vs 1.233 +/- 0.238, P < 0.001) and protein levels (34.2% vs 13.2%, P = 0.003) in gastric cancer tissues. Correlation analysis demonstrated that high expression of MR-1 in gastric cancer was significantly correlated with clinical stage (P = 0.034). Kaplan-Meier analysis showed that the postoperative survival of the MR-1 positive group tended to be poorer than that of the MR-1 negative group, and the difference was statistically significant (P = 0.002). Among all the patients with stage I-IV carcinoma, the 5-year survival rates of MR-1 positive and negative groups were 50.40% and 12.70%, respectively, with respective median survival times of 64.27 mo (95%CI: 13.41-115.13) and 16.77 mo (95%CI: 8.80-24.74). Univariate and multivariate analyses were performed to compare the impact of MR-1 expression and other clinicopathological parameters on prognosis. In a univariate analysis on all 70 specimens, 6 factors were found to be significantly associated with the overall survival statistically: including MR-1 expression, depth of invasion, distant metastasis, lymph node metastasis, vascular invasion and the tumor node metastasis (TNM) stage based on the 7th edition of the International Union against Cancer TNM classification. To avoid the influence caused by univariate analysis, the expressions of MR-1 as well as other parameters were examined in multivariate Cox analysis. Clinicopathological variables that might affect the prognosis of gastric cancer patients were analyzed by Cox regression analysis, which showed that MR-1 expression and TNM stage were independent predictors of postoperative survival. The best mathematical multivariate Cox regression model consisted of two factors: MR-1 expression and TNM stage. Our results indicated that MR-1 protein could act as an independent marker for patient overall survival [Hazard ratio (HR): 2.215, P = 0.043].CONCLUSION: MR-1 is an important variable that can be used to evaluate the outcome, prognosis and targeted therapy of gastric cancer patients. (C) 2012 Baishideng. All rights reserved.

Brg1 Gene Mutation and the Protein Expression in Gastric Carcinoma

Study on relationship between mutant p53 and multidrug resistance gene 1 in gastric cancer

Expression of Ngf Family and Their Receptors in Gastric Carcinoma: A Cdna Microarray Study

THE EXPRESSIONS AND LOCALIZATIONS OF B7-H1 IN DIFFERENT GASTRIC CANCER CELL LINES

Preliminary Study on the Cause of BRG1 Down-Expression in Primary Lung Cancers and Multiple Tumor Cell Lines

Expression and significance of BRCA1 in patients with advanced gastric cancer

Analysis of BRG1 Expression in Primary Lung Cancers and Multiple Tumor Cell Lines

Expression of BRG1 and BRM Proteins in Prostatic Cancer

[The Relation Between Reg 1A Mrna Expression and the Clinicopathologic Parameters in the Patients with Primary Gastric Carcinoma].

Up-regulated Expression of Co-stimulatory Molecule B7-H1 in Gastric Carcinoma

Expression and Clinical Significance of Tumor Suppressor Gene RRM1 in Carcinogenesis and Progression of Gastric Cancer

Clinicopathological Significance, Related Molecular Changes and Tumor Immune Response Analysis of the Abnormal SWI/SNF Complex Subunit PBRM1 in Gastric Adenocarcinoma.

The Relationship between the Expression of P73, E2F-1 and Bcl-2 and the Biological Behavior in Human Gastric Carcinoma.

Expression and clinical significance of Bmi-1 in gastric carcinoma

Expression of P21, P27, P53 and Rb Proteins and Their Clinical Significance in Gastric Carcinoma

HGC - 1 expression in gastric carcinoma and its relationship with clinicopathological fac-tors and prognosis

The NDRG1 Expression and the Prognosis in Patients of Gastric Carcinoma

Myofibrillogenesis Regulator-1 Overexpression is Associated with Poor Prognosis of Gastric Cancer Patients

BRCA1 and BRCA2 expression patterns and prognostic significance in digestive system cancers.

Expression of P53, EGFR, HER-2, VEGF in Gastric Carcinoma and Its Relation with the Prognosis of Gastric Carcinoma Patients

BRG1 Promotes Hepatocarcinogenesis by Regulating Proliferation and Invasiveness